Regeneron Highlights New Real-World And Clinical Data On EYLEA HD At ARVO 2025
29/4 00:47
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) announced the presentation of 27 abstracts, including eight oral sessions, featuring EYLEA HD (aflibercept) Injection 8 mg at the upcoming ARVO 2025 Annual Meeting, taking place from May 4-8 in Salt Lake City....